English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 906338      Online Users : 899
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version
    Siblings
    Books/Book Section [0/1]
    Conference Papers/Meeting Abstract [22/23]

    Collection Statistics

    Item counts issued in 3 years:21(19.81%)
    Items With Fulltext:105(99.06%)

    Download counts of the item
    Download times greater than 0:105(100.00%)
    Download times greater than 100:105(100.00%)
    Total Bitstream Download Counts:43158(80.26%)

    Last Update: 2024-12-01 00:24


    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 76-100 of 106. (5 Page(s) Totally)
    << < 1 2 3 4 5 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2014-04 The association of genetic polymorphisms in the kappa-opioid receptor 1 gene with body weight, alcohol use, and withdrawal symptoms in patients with methadone maintenance Journal of Clinical Psychopharmacology. 2014 Apr;34(2):205-211.
    2013-12 Genetics and pharmacogenetics of substance use disorders Journal of Food and Drug Analysis. 2013 Dec;21(4 Suppl.):S23-S24.
    2013-12 Pharmacogenomics study in a Taiwanese methadone maintenance cohort Journal of Food and Drug Analysis. 2013 Dec;21(4 Suppl.):S62-S68.
    2013-11 Comparison of escitalopram and paroxetine in the treatment of major depressive disorder International Clinical Psychopharmacology. 2013 Nov;28(6):339-345.
    2013-09 Functional genetic polymorphisms in CYP2C19 Gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort OMICS :A Journal of Integrative Biology. 2013 Sep;17(10):519-526.
    2013-07-23 Hepatitis C Virus infection influences the S-methadone metabolite plasma concentration PLoS ONE. 2013 Jul 23;8(7):Article number e69310.
    2013-07 CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions Pharmacogenomics. 2013 Jul;14(10):1191-1201.
    2013-03-28 The DAO gene is associated with schizophrenia and interacts with other genes in the Taiwan Han Chinese population PLoS ONE. 2013 Mar 28;8(3):Article number e60099.
    2013-02 OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: A cross sectional study Journal of Human Genetics. 2013 Feb;58(2):84-90.
    2013-02 PXR polymorphisms interacted with CYP2B6 polymorphisms on methadone metabolites Journal of Clinical Psychopharmacology. 2013 Feb;33(1):137-140.
    2012-10 Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients European Neuropsychopharmacology. 2012 Oct;22(10):695-703.
    2012-06 UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients Pharmacogenomics. 2012 Jun;13(8):879-888.
    2012-03 Genome-wide association study of treatment refractory schizophrenia in Han Chinese PLoS ONE. 2012 Mar;7(3):Article number e33598.
    2011-12 Aripiprazole and dehydroaripiprazole plasma concentrations and clinical responses in patients with schizophrenia Journal of Clinical Psychopharmacology. 2011 Dec;31(6):758-762.
    2011-10 Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients Pharmacogenomics. 2011 Oct;12(10):1397-1406.
    2011-08 CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer Journal of Clinical Psychopharmacology. 2011 Aug;31(4):463-469.
    2011-06 ANXA7, PPP3CB, DNAJC9, and ZMYND17 Genes at chromosome 10q22 associated with the subgroup of schizophrenia with deficits in attention and executive function Biological Psychiatry. 2011 Jul;70(1):51-58.
    2011-04 ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment Pharmacogenetics and Genomics. 2011 Apr;21(4):163-170.
    2010-11 CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine Pharmacogenomics. 2010 Nov;11(11):1535-1543.
    2010-07 Development of a method to measure methadone enantiomers and its metabolites without enantiomer standard compounds for the plasma of methadone maintenance patients Biomedical Chromatography. 2010 Jul;24(7):782-788.
    2010-04 Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response Pharmacogenomics. 2010 Apr;11(4):537-546.
    2010-01-14 Genetic variants of IL-6 and its receptor are not associated with schizophrenia in Taiwan Neuroscience Letters. 2010 Jan 14;468(3):330-333.
    2009-11 Clustering by neurocognition for fine mapping of the schizophrenia susceptibility loci on chromosome 6p Genes, Brain and Behavior. 2009 Nov;8(8):785-794.
    2009-07 Construction of Balanced Translocation t(1;11)(q42.1;q14.3) Probe and Screening Application in Genomic Samples in Taiwan Journal of the Formosan Medical Association. 2009 Jul;108(7):587-591.
    2009-04 Association of the 3'region of COMT with Schizophrenia in Taiwan Journal of the Formosan Medical Association. 2009 Apr;108(4):301-309.

    Showing items 76-100 of 106. (5 Page(s) Totally)
    << < 1 2 3 4 5 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback